Page last updated: 2024-09-03

sk&f 86466 and 1,3-dipropyl-8-cyclopentylxanthine

sk&f 86466 has been researched along with 1,3-dipropyl-8-cyclopentylxanthine in 1 studies

Compound Research Comparison

Studies
(sk&f 86466)
Trials
(sk&f 86466)
Recent Studies (post-2010)
(sk&f 86466)
Studies
(1,3-dipropyl-8-cyclopentylxanthine)
Trials
(1,3-dipropyl-8-cyclopentylxanthine)
Recent Studies (post-2010) (1,3-dipropyl-8-cyclopentylxanthine)
73391,3011165

Protein Interaction Comparison

ProteinTaxonomysk&f 86466 (IC50)1,3-dipropyl-8-cyclopentylxanthine (IC50)
Adenosine receptor A1Rattus norvegicus (Norway rat)0.0051
Adenosine receptor A3Rattus norvegicus (Norway rat)0.0038
Adenosine receptor A2aHomo sapiens (human)0.2033
Adenosine receptor A2bHomo sapiens (human)0.0234
Adenosine receptor A1Homo sapiens (human)0.0083

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1

Other Studies

1 other study(ies) available for sk&f 86466 and 1,3-dipropyl-8-cyclopentylxanthine

ArticleYear
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009